BIVDA Press Releases

23Feb

Member Press Release - BIVDA Member Randox Processes 10 Millionth COVID-19 Test

RANDOX PROCESSES ITS 10 MILLIONTH COVID-19 TEST AND DETAILS INVESTMENT IN TESTING CAPACITY

 

Randox Laboratories has confirmed that it has processed its 10 millionth sample for the UK’s COVID-19 National Testing Programme, making it the first Pillar 2 testing laboratory to achieve this milestone.  This achievement is based upon a £85 million investment since March 2020 in facilities and equipment at Randox’s laboratories in Northern Ireland.

 

As a key partner laboratory from initiation of the UK’s National Testing Programme in March 2020, Randox quickly ramped up its testing capacity.  Randox’s response has involved recruitment of over 850 new staff , the building and equipping of over 80,000 sq ft of new molecular laboratory space and the development of new innovations in testing technology. These efforts have seen Randox’s COVID-19 testing capacity grow from 150 tests per day in March 2020 to over 120,000 samples per day today, making Randox the largest throughput laboratory in the UK and Ireland and amongst the biggest in Europe.

 

Randox Founder and Managing Director, Dr Peter FitzGerald, said: This milestone is an incredible achievement and testament to the dedication and hard work of our teams, who have pulled together at a time of national crisis and whose non-stop efforts are vital to enable the country to return to both social and economic normality.

 

“We will continue to build our capacity and develop new cutting-edge testing equipment to support the fight against COVID-19.   We’ve all learnt from this pandemic the importance of early and accurate testing and Randox is committed to investing in diagnostic technology to meet future health challenges.”

 

  • ENDS -

 

Notes to editors

Randox is an international medical diagnostics company based in Antrim, Northern Ireland. Since its establishment in 1982, Randox has become a prominent world-leader in medical diagnostics and associated research and development, transforming the way patients are diagnosed and treated in over 145 countries. Randox is a premium provider of comprehensive health check services designed to empower its customers to take control of their health.

 

 

 

Related

BIVDA comment on Withdrawal Agreement and political declaration

Doris-Ann Williams, Chief Executive of BIVDA, comments on the announcement of the Withdrawal Agreeme...

Read More >

All Party Parliamentary Group to raise the profile of the UK Life Sciences sector

This week marked the relaunch of the All Party Parliamentary Group (APPG) for Life Sciences.

Read More >

UN International Day of Women and Girls in Science

BIVDA celebrates International Day of Women and Girls in Science

Read More >

BIVDA Press Comment - Doris-Ann Williams welcomes Sajid Javid to his new position at DHSC

Please see below a quote from Doris-Ann Williams, CEO of BIVDA, welcoming the new Secretary of State...

Read More >

Member Press Release - EKF opens larger facility to increase production of key component for COVID-19 testing regime

Cardiff, UK – 21st January 2021 – EKF Diagnostics, the global in vitro diagnostics compa...

Read More >